Ol'binskaia L I, Golokolenova G M
Klin Med (Mosk). 1990 Jan;68(1):39-42.
A clinical trial of Soviet drug mildronate has proved its antiarrhythmic action, the ability to prevent ventricular extrasystoles, to reduce asthenia, to enhance physical performance and adaptive reactions. The heart rate decrease appeared insignificant. Intravenous administration of the drug improves myocardial contractility. Mildronate is well tolerated. No side effects were registered.
苏联药物米屈膦酸盐的一项临床试验已证明其抗心律失常作用、预防室性早搏的能力、减轻乏力、增强身体机能和适应性反应的能力。心率下降似乎不显著。静脉注射该药物可改善心肌收缩力。米屈膦酸盐耐受性良好。未记录到副作用。
